170651 ⎘
Assays involving biological materials from specific organisms or of a specific nature; Enzymes; Proenzymes; Hydrolases (3) acting on glycosyl compounds (3.2)
Sub-classes:INTELLIGENT NIR II PHOTOTHERMAL AND COLORIMETRIC SENSING TECHNOLOGY
#2POMPE DISEASE MOUSE MODEL GENERATION, CHARACTERIZATION AND METHODS OF USE
#3CAS12A COMPOSITIONS AND METHODS
#4COMPOUNDS AND METHODS RELATING TO TESTING FOR LYSOSOMAL STORAGE DISORDERS
#5ENDOGLYCOSIDASE-ASSISTED PEPTIDE MAPPING
#6Method of Nucleic Acid Sequencing
#7BIOMARKERS
#8DETECTION OF KLOTHO
#9METHODS AND COMPOSITIONS FOR ASSAYING BETA-HEXOSAMINIDASE ENZYMATIC ACTIVITY VIA MASS SPECTROMETRY
#10BIOSENSORS AND USES THEREOF
#11BIOLOGICAL DEVICES FOR THE DETECTION OF ALZHEIMER'S DISEASE AND CONCUSSIONS AND METHODS OF USE THEREOF
#12METHOD FOR COMBINED GENOME METHYLATION AND VARIATION ANALYSES
#13METHOD FOR THE SYNTHESIS OF EVOC PROBES
#14READY-TO-CONSTITUTE ANALYTICAL PLATFORMS FOR CHEMICAL ANALYSES AND QUANTIFICATION OF ANALYTES IN BIOLOGICAL SAMPLES
#15BIOMARKERS FOR SEVERITY OF ISCHEMIC STROKE AND USE THEREOF
#16NOVEL ANTI-CD38 ANTIBODIES FOR THE TREATMENT OF CANCER
#17TARGETED MASS SPECTROMETRY METHODOLOGY FOR DETECTING KLOTHO ISOFORMS
#18DNA Methylation Library Construction Method and Library Obtained with Same, DNA Hybridization and Capture Method and Kits
#19MATERIALS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF CANCER
#20SENOTHERAPEUTIC AGENTS AND ALPHA-KLOTHO POLYPEPTIDES
#21ENZYMES AND USES THEREOF
#22METHODS FOR USE OF VIRAL VECTOR CONSTRUCTS FOR THE TREATMENT OF FABRY DISEASE
#23SUBSTRATES FOR IMAGING GLUCOCEREBROSIDASE ACTIVITY
#24Methods for Categorizing and Treating Subjects at Risk for Pulmonary Exacerbation and Disease Progression
#25ASSAY METHOD OF ANTIBODY
#26METHODS OF BIOMOLECULE DISPLAY
#27METHOD FOR DETECTING KIDNEY DYSFUNCTION DIAGNOSTIC MARKER, METHOD FOR DETERMINING RENAL PROGNOSIS, DETECTION KIT FOR KIDNEY DYSFUNCTION DIAGNOSTIC MARKER, AND KIDNEY DYSFUNCTION DIAGNOSTIC MARKER
#28METHOD FOR RAPIDLY AND ACCURATELY DETECTING HOP LATENT VIROID RNA
#29PRODUCTS AND METHODS FOR ASSESSING AND INCREASING KLOTHO PROTEIN LEVELS
#30DUAL CAPTURE METHOD FOR ANALYSIS OF ANTIBODY-DRUG CONJUGATES
#31METHODS AND SYSTEMS FOR EXTENDING DYNAMIC RANGE IN ASSAYS FOR THE DETECTION OF MOLECULES OR PARTICLES
#32PROBES BASED ON VOLATILE ORGANIC COMPOUNDS AND USES THEREOF FOR THE DIAGNOSIS AND PROGNOSIS OF PATHOLOGICAL CONDITIONS
#33COMPOSITIONS AND METHODS FOR TREATING EYE INFECTIONS AND DISEASE
#34SMALL-MOLECULE-ACTIVATED GLYCAN MODIFYING ENZYMES AND USES THEREOF
#35GAL3BP POLYPEPTIDE COMPOSITIONS AND METHODS FOR TREATMENT OF CANCER AND DETERMINING TREATMENT RESPONSIVENESS
#36METHODS FOR TREATING INHERITED METABOLIC DISORDERS
#37INHIBITION OF CASPASE PATHWAY AS A TREATMENT FOR LYSOSOMAL STORAGE DISORDERS
#38MATERIALS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF CANCER
#39Identification of inhibitors of TcpC and TIR NADase activity
#40Protease and Binding Polypeptide for O-Glycoproteins
#41REAGENTS AND METHODS FOR SCREENING MPS I, II, IIIA, IIIB, IVA, VI, AND VII
#42KIDNEY HEALTH MONITORING IN HYPERTENSION PATIENTS
#43METHOD FOR DETECTING OPIOIDS, OPIATES, CANNABINOIDS, OR BENZODIAZEPINES IN A SAMPLE WITH A B-GLUCURONIDASE ENZYME
#44LABEL-FREE N-GLYCAN QUANTIFICATION METHODS
#45METHODS OF TREATING DEMENTIA ASSOCIATED WITH ALZHEIMER'S DISEASE WITH PROTECTIVE PROTEIN/CATHEPSIN A (PPCA)
#46ANALYSIS METHOD AND ANALYSIS DEVICE
#47Methods for the rapid preparation of labeled glycosylamines and for the analysis of glycosylated biomolecules producing the same
#48Methods for categorizing and treating subjects having cystic fibrosis (CF) and at risk for severe pulmonary exacerbation
#49Methods for Treatment of Fabry Disease
#50METHODS AND KITS FOR THE DIAGNOSIS OF INFLUENZA
#51LIGAND-FUNCTIONALIZED SUBSTRATES WITH ENHANCED BINDING CAPACITY
#52Compounds and methods relating to lysosomal storage disorders
#53Methods and systems for extending dynamic range in assays for the detection of molecules or particles
#54COMPOSITIONS AND METHODS FOR TREATING EYE INFECTIONS AND DISEASE
#55METHODS OF MEASURING ENZYME ACTIVITY IN COATING COMPOSTIONS
#56Manufacture of active highly phosphorylated human lysosomal sulfatase enzymes and uses thereof
#57METHODS FOR TREATING AMYOTROPHIC LATERAL SCLEROSIS (ALS)
#58Allosteric Split Trehalase Biosensor
#59PHENOXY THIOPHENE SULFONAMIDES AND OTHER COMPOUNDS FOR USE AS INHIBITORS OF BACTERIAL GLUCURONIDASE
#60METHODS OF DIAGNOSING A DISEASE AND METHODS OF MONITORING TREATMENT OF A DISEASE BY QUANTIFYING A NON-REDUCING END GLYCAN RESIDUAL COMPOUND AND COMPARING TO A SECOND BIOMARKER
#61Sialic acid binding polypeptide
#62CHITINASE PROTEINS IN NEUROLOGIC DISEASE
#63NOVEL ANTI-CD38 ANTIBODIES FOR THE TREATMENT OF CANCER
#64Method for detecting enzymatic reaction product
#65Method of selecting a probiotic
#66IDENTIFICATION OF INHIBITORS OF TCPC AND TIR NADase ACTIVITY
#67Methods for Categorizing and Treating Subjects at Risk for Pulmonary Exacerbation and Disease Progression
#68Ligand-functionalized substrates with enhanced binding capacity
#69Bis-acetal-based substrates for imaging exo-glycosidase activity
#70Manufacture of active highly phosphorylated human lysosomal sulfatase enzymes and uses thereof
#71COMPOSITIONS AND METHODS FOR TREATING EYE INFECTIONS AND DISEASE
#72Protease and binding polypeptide for O-glycoproteins
#73SULFONYLUREA COMPOUNDS IN THE TREATMENT OF DISEASE ASSOCIATED WITH UV-INDUCED DAMAGE
#74Electrochemical methods and compounds for the detection of enzymes
#75ASSAY
#76METHODS OF TREATING DEMENTIA ASSOCIATED WITH ALZHEIMER'S DISEASE WITH PROTECTIVE PROTEIN/CATHEPSIN A (PPCA)
#77Enzymes for Glycan Analysis
#78Fluorogenic glycosidase substrate and associated detection method
#79Methods for treatment of Fabry disease
#80Methods and kits for the diagnosis of influenza
#81Ligand-functionalized substrates with enhanced binding capacity
#82Method of measuring the deleterious effects of non-caloric artificial sweeteners on enzymatic hydrolysis of sucrose measured in real time
#83Allosteric split trehalase biosensor
#84Quantification of non-reducing end glycan residual compounds for determining the presence, identity, or severity of a disease or condition
#85Compositions and methods for neuraminidase detection and quantification
#86Methods and kits for assessing Heparanase procoagulant activity, compositions comprising Heparanase, and methods for the treatment of coagulation-related disorders
#87TOXIN ACTIVITY ASSAYS, DEVICES, METHODS AND SYSTEMS THEREFOR
#88Method and kit for detecting pathogenic microorganism
#89Nucleic acids encoding antibodies with high affinity for Alpha-Klotho
#90Reagents and methods for screening MPS I, II, IIIA, IIIB, IVA, VI, and VII
#91Methods for categorizing and treating subjects at risk for pulmonary exacerbation and disease progression
#92Function-based probes for environmental microbiome analysis and methods of making and using the same
#93Method for immobilization of glucuronidase enzymes for the detection of products derived from glucuronide compounds
#94Methods for treatment of Fabry disease
#95Quantitation of glycan moiety in recombinant glycoproteins
#96Identification of glycosylation forms
#97Cleavage of Fucose in N-Glycans
#98Methods of diagnosing mucopolysaccharidosis (MPS) I and methods of monitoring treatment of MPS by quantifying a non-reducing end glycan residual compound and comparing to a second biomarker
#99Methods for treatment of fabry disease
#100Methods and systems for extending dynamic range in assays for the detection of molecules or particles
#101MODULATING URACIL-DNA GLYCOSYLASE AND USES THEREOF
#102Ligand-functionalized substrates with enhanced binding capacity
#103Manufacture of active highly phosphorylated human lysosomal sulfatase enzymes and uses thereof
#104Methods for the rapid preparation of labeled glycosylamines and for the analysis of glycosylated biomolecules producing the same
#105METHODS AND KITS FOR CANCER ANTIGEN AND HEPARAN SULFATE IMAGING
#106Crystal structure of Autolysin E, method of producing the crystal and its use in screening methods
#107Ultra-high-sensitive assay of protein and nucleic acid and kit, and novel enzyme substrate
#108Methods and kits for assaying endoglycosidase activity
#109Methods of treating dementia associated with Alzheimer's disease with protective protein/cathepsin A (PPCA)
#110Enzymatic activity assays for glucocerebrosidase
#111Charged reactive oligomers
#112Electrochemical detection of microorganisms
#113Human neutralizing antibodies binding to influenza neuraminidase
#114Reactive labelling compounds and uses thereof
#115METHODS OF MONITORING ADHERENCE TO QUETIAPINE THERAPY
#116NOVEL ANTI-CD38 ANTIBODIES FOR THE TREATMENT OF CANCER
#117ANALYSIS METHOD AND ANALYSIS DEVICE
#118BIOMASS CONTAINMENT DEVICE
#119Sialyltransferase ST3GAL6 as a marker for multiple myeloma
#120Compositions and methods for treating eye infections and disease
#121COMPOSITIONS AND METHODS FOR TREATING EYE INFECTIONS AND DISEASE
#122Quantification of non-reducing end glycan residual compounds for determining the presence, identity, or severity of a disease or condition
#123Determination of ligninases activities by nano-structure initiator mass spectrometry
#124Potent anti-influenza A neuraminidase subtype N1 antibody
#125Analytical Methods and Arrays for Use in the Same
#126Method of measuring alpha amylase
#127Mutant lactobacillus beta-glucuronidase enzymes with enhanced enzymatic activity
#128Lysosome membrane protein 2 (LIMP-2) based peptides and related uses
#129Apparatuses, methods, computer program products, and kits for hi-throughput glycan analysis
#130Method of detection of analyte active forms and determination of the ability of substances to bind into analyte active sites
#131Antibodies with high affinity for alpha-Klotho
#132Genetic signature of vulnerability to inhibitors of base excision repair (BER) in cancer
#133Compositions and methods for treating eye infections and disease
#134Antibodies directed to ricin toxin
#135Reagents and methods for detecting influenza
#136GLUCANASES, NUCLEIC ACIDS ENCODING THEM AND METHODS FOR MAKING AND USING THEM
#137Methods for the diagnosis and treatment of pulmonary fibrosis in subjects with hermansky pudlak syndrome
#138A-fucosylation detection in antibodies
#139Electrochemical methods and compounds for the detection of enzymes
#140Methods for treatment of Fabry disease
#141SMALL MOLECULE INHIBITORS OF 8-OXOGUANINE DNA GLYCOSYLASE-1 (OGG1)
#142Methods of detecting influenza virus
#143IN-SILICO BASED TECHNIQUES IN THE IDENTIFICATION OF POTENT ß-GLUCORONIDASE INHIBITORS
#144Methods and kits for assessing heparanase procoagulant activity, compositions comprising heparanase, and methods for the treatment of coagulation related disorders
#145Methods of determining the presence, identity, and/or severity of mucopolysaccharidosis (MPS) VI and IVA
#146Methods and compositions to detect the level of lysosomal exocytosis activity and methods of use
#147Analytical method for determining the concentration of oxidized nanofibrillar cellulose in a sample
#148Compounds and methods relating to lysosomal storage disorders
#149Reagents and methods for screening MPS I, II, IIIA, IIIB, IVA, VI, and VII
#150Method for detecting bacteriolytic conditions in a sample
#151Chromogenic glucuronidase substrates and uses
#152METHOD FOR DETERMINING HIGH-MANNOSE GLYCANS
#153Composition for diagnosing pancreatic cancer and method for diagnosing pancreatic cancer using same
#154PHENOXY THIOPHENE SULFONAMIDES AND OTHER COMPOUNDS FOR USE AS INHIBITORS OF BACTERIAL GLUCURONIDASE
#155MULTIDRUG ANALYSIS IN URINE BY LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY
#156Ligand functionalized substrates with enhanced binding capacity
#157Manufacture of active highly phosphorylated human lysosomal sulfatase enzymes and uses thereof
#158TOXIN ACTIVITY ASSAYS, DEVICES, METHODS AND SYSTEMS THEREFOR
#159Quantification of non-reducing end glycan residual compounds for determining the presence, identity, or severity of a disease or condition
#160Antibodies directed to ricin toxin
#161BACTERIAL LYSINS AND USES THEREOF
#162Antibodies or fragments thereof directed against a epitope of IsaA or IsaB
#163Selective glycosidase inhibitors and uses thereof
#164ENZYMATIC HYDROLYSIS OF GLUCURONIDE CONJUGATED DRUGS IN THE PRESENCE OF WATER MISCIBLE ORGANIC MEDIA
#165METHODS FOR DETERMINING PRESENCE OR ABSENCE OF GLYCAN EPITOPES ON GLYCOPROTEINS
#166Methods relating to testing for lysosomal storage disorders
#167BIOSENSORS UTILIZING INK JET-PRINTED BIOMOLECULE COMPATIBLE SOL GEL INKS AND USES THEREOF
#168Method and kits for the diagnosis of influenza
#169Method for preparing glycan-hydrolyzed antibody, and homogeneous glycosylated antibody
#170Methods and systems for extending dynamic range in assays for the detection of molecules or particles
#171SIALYLTRANSFERASE ST3GAL6 AS A MARKER FOR MULTIPLE MYELOMA
#172Methods for assaying alpha-L-iduronidase enzymatic activity
#173Non-invasive diagnostic method for the evaluation of intestinal lactase deficiency (hypolactasia)
#174ORAL PREPARATION, INJECTION PREPARATION, EXTERNAL SKIN PREPARATION AND COSMETIC METHOD FOR PREVENTING OR IMPROVING WRINKLES
#175Method for treating pulmonary exacerbation and disease progression in subjects having cystic fibrosis
#176Reactive labelling compounds and uses thereof
#177Fluorogenic glycosidase substrate and associated detection method
#178ANALYSIS OF DISULFIDE BONDS
#179Cell based sensor
#180Methods for treatment of Fabry disease
#181Intracellular organelle peptide targeted enzyme substrates
#182CLINICAL DIAGNOSIS OF HEPATIC FIBROSIS USING A NOVEL PANEL OF LOW ABUNDANT HUMAN PLASMA PROTEIN BIOMARKERS
#183Compositions and methods for treating type III gaucher disease
#184Assay for measuring enzymatic modification of a substrate by a glycoprotein having enzymatic activity
#185Selective glycosidase inhibitors and uses thereof
#186High-Throughput Method For Sialic Acid Quantitation
#187Crystal structure of human α-N-acetylglucosaminidase
#188METHODS AND COMPOSITIONS TO DETECT THE LEVEL OF LYSOSOMAL EXOCYTOSIS ACTIVITY AND METHODS OF USE
#189Methods of diagnosing a disease and methods of monitoring treatment of a disease by quantifying a non-reducing end glycan residual compound and comparing to a second biomarker
#190Quantification of non-reducing end glycan residual compounds for determining the presence, identity, or severity of a disease or condition
#191Enzymatic activity based-detection
#192Selective glycosidase inhibitors and uses thereof
#193Treatment of proteinopathies
#194Selective glycosidase inhibitors and uses thereof
#195Compositions and methods for treating Gaucher disease
#196Glucanases, nucleic acids encoding them and methods for making and using them
#197Methods of treating alzheimer's disease by administration of protective protein/cathepsin A
#198Methods and compositions for detecting and modulating O-glycosylation
#199Rapid and accurate analysis of protein sialylation
#200Selective glycosidase inhibitors and uses thereof
#201Rational design of components of the oligo-saccharyltransferase-catalysed asparagine-linked glycosylation
#202Derivatization of PNGase F released glycans on an HPLC chip
#203Biomarkers for acute kidney injury
#204Ultra-high-sensitive assay of protein and nucleic acid and kit, and novel enzyme substrate
#205Phenoxy thiophene sulfonamides and their use as inhibitors of glucuronidase
#206Manufacture of active highly phosphorylated human lysosomal sulfatase enzymes and uses thereof
#207High mannose glycans
#208Activity based probes (ABPs) interacting with glycosidases
#209Method of diagnosing and preventing pneumococcal diseases using pneumococcal neuraminidases
#210Chitinase-3-Like Protein 1 as a Biomarker of Recovery from Kidney Injury
#211Targeted therapeutic proteins
#212Enzymatic activity-based detection
#213Method for detecting a wound infection
#214Methods for treatment of Fabry disease
#215EXTRACELLULAR YALURONIDASE FROM STREPTOMYCES KOGANEIENSIS
#216Manufacture of active highly phosphorylated human lysosomal sulfatase enzymes and uses thereof
#217Autism-associated biomarkers and uses thereof
#218A-FUCOSYLATION DETECTION IN ANTIBODIES
#219NOVEL ROLE OF ALPHA-GALACTOSIDASE ACTIVITY AS A BIOMARKER IN KIDNEY DISEASE
#220Method of analyzing cellulose decay in lignocellulosic material hydrolysis
#221Enzymatic substrates for multiple detection systems
#222Non-invasive diagnostic method for the evaluation of intestinal lactase deficiency (hypolactasia)
#223METHODS AND KITS FOR MEASURING ENZYME ACTIVITY
#224NOVEL ANTI-CD38 ANTIBODIES FOR THE TREATMENT OF CANCER
#225Reagents and methods for detecting influenza virus proteins
#226Biosensors utilizing ink jet-printed biomolecule compatible sol gel inks and uses thereof
#227Media For The Specific Detection Of Gram-Negative Bacteria Resistant To Beta-Lactam Antibiotics
#228INFECTION DETECTION METHODS AND SYSTEMS AND RELATED COMPOUNDS AND COMPOSITIONS
#229BIOMARKERS FOR DETECTION AND DIAGNOSIS OF HEAD AND NECK SQUAMOUS CELL CARCINOMA
#230Antibodies or fragments thereof directed against a epitope of ISAA or ISAB
#231METHOD FOR DIAGNOSING POMPE DISEASE
#232EXTRACELLULAR YALURONIDASE FROM STREPTOMYCES KOGANEIENSIS
#233Methods for assaying α-L-iduronidase enzymatic activity
#234DETECTION OF TRICHOMONAS AND CANDIDA
#235GLUCANASES, NUCLEIC ACIDS ENCODING THEM AND METHODS FOR MAKING AND USING THEM
#236Crystal structure of human alpha-N-acetylglucosaminidase
#237METHODS AND KITS FOR DETERMINING PREDISPOSITION TO CANCER
#238METHODS AND KITS FOR DETERMINING A RISK TO DEVELOP CANCER, FOR EVALUATING AN EFFECTIVENESS AND DOSAGE OF CANCER THERAPY AND FOR CORRELATING BETWEEN AN ACTIVITY OF A DNA REPAIR ENZYME AND A CANCER
#239NOVEL ANTI-CD38 ANTIBODIES FOR THE TREATMENT OF CANCER
#240N-METHYLPURINE DNA GLYCOSYLASE AND POLYMERASE BETA AS BIOMARKERS FOR ALKYLATOR CHEMOTHERAPY POTENTIATION
#241Methods and systems for extending dynamic range in assays for the detection of molecules or particles
#242Reagents and kits for detection of influenza virus and the like
#243ALZHEIMER'S DISEASE BIOMARKERS AND METHODS OF USE
#244METHOD OF PREDICTING DRUG-INDUCED PHOSPHOLIPIDOSIS
#245ASSAYS FOR DIAGNOSING AND EVALUATING TREATMENT OPTIONS FOR FABRY DISEASE
#246High-Throughput Method for Quantifying Sialylation of Glycoproteins
#247CLASSIFICATION OF INDIVIDUALS SUFFERING FROM CARDIOVASCULAR DISEASES ACCORDING TO SURVIVAL PROGNOSES AS FOUND BY MEASURING THE LEVELS OF BIOMARKER YKL-40
#248Compositions and assays for treatment and diagnosis of helicobacter pylori infection and conditions
#249System for detecting microbial contamination
#250Diagnosis and treatment of autism using CD38
#251COMPOSITIONS AND METHODS FOR TREATING GAUCHER DISEASE
#252Method for analyzing a glycomolecule
#253ORAL PREPARATION, INJECTION PREPARATION, EXTERNAL SKIN PREPARATION AND COSMETIC METHOD FOR PREVENTING OR IMPROVING WRINKLES
#254Detection of endometrial secretion markers for assessment of endometriosis
#255System for detecting microbial contamination
#256Early detection of diabetes
#257Compositions and methods for pest control
#258Clinical diagnosis of hepatic fibrosis using a novel panel of low abundant human plasma protein biomarkers
#259Methods and compositions for detections and modulating O-glycosylation
#260Use of a L. Casei Strain For the Preparation of a Composition for Inhibiting Mast Cell Activation
#261Methods and kit for endometriosis screening
#262Methods for preventing and/or treating lysosomal storage disorders
#263BIOCHEMICAL TEST FOR CONFIRMING THE PRESENCE OF L. MONOCYTOGENES
#264METHODS FOR DETECTING AND MEASURING POLYSACCHARIDE-HYDROLYZING ENZYMES
#265Ionic complex nanoparticles for detecting heparanase activities and method for preparing the same
#266Methods for assaying alpha-L-iduronidase enzymatic activity
#267LYSINE ACETYLATION SITES
#268Acquisition method for biological rhythm information
#269Method for identifying smoker or ex-smoker at risk of chronic obstructive pulmonary disease
#270Quantification of non-reducing end glycan residual compounds
#271Methods for determining cellulolytic enhancing activity of a polypeptide
#272Characterization of -glycans using exoglycosidases
#273Human beta-glucuronidase mutants with elevated enzymatic activity under physiological conditions and method for identifying such
#274Method for determining endoglycosidase (heparanase) enzyme activity
#275BIORHYTHM INFORMATION ACQUISITION METHOD
#276Targeted therapeutic proteins
#277Cosmetic use of chitinase-type proteins
#278Enzyme assays for a droplet actuator
#279Detection method for influenza viruses
#280Biomarkers for detection and diagnosis of head and neck squamous cell carcinoma
#281Anti-CD38 antibodies for the treatment of cancer
#282Fluorescence assays with improved sensitivity
#283Enzymatic substrates for multiple detection systems
#284Manufacture of active highly phosphorylated human lysosomal sulfatase enzymes and uses thereof
#285DETERMINATION OF VIABLE MICROORGANISMS USING COATED PARAMAGNETIC BEADS
#286Polysaccharide structure and sequence determination
#287Mucopolysaccharidosis (MPS) diagnostic methods, systems, kits and assays associated therewith
#288Saccharidic fluorescent substrates, their process of preparation and their use
#289Method of Excising Sugar Chain from Glycoprotein, Method of Mass Spectrometry of Sugar Chain, and Method of Mass Spectrometry of Glycoprotein
#290Culture medium for detecting and identifying bacteria
#291NOVEL PRIMATE CHITINASES AND USES THEREFOR
#292Saccharide fluorescent substrates, preparation method and uses thereof
#293Reagents and kits for detection of influenza virus and the like
#294Methods for identifying anti-tumor and/or anti-angiogenesis drugs with deoxynucleoside 5′-monophosphate N-glycosidase as the target
#295FGF21 upregulates expression of GLUT-1 in a βklotho-dependent manner
#296Methods for detection of lysosomal storage disease
#297Methods for detection of lysosomal storage disease
#298Glucanases, nucleic acids encoding them and methods for making and using them
#299Polysaccharide structure and sequence determination
#300Compositions and methods for detection of lysosomal storage disease